M. Gamba

发表

Differences in outcomes in patients with stable coronary artery disease managed by cardiologists versus noncardiologists. Results from the international prospective CLARIFY registry.

J. Tardif, K. Fox, R. Ferrari, 2017, Polish archives of internal medicine.

Gender differences and management of stroke risk of nonvalvular atrial fibrillation in an upper middle-income country: Insights from the CARMEN-AF registry☆

M. Márquez, José del Valle, M. Guevara-Valdivia, 2019, International journal of cardiology. Heart & vasculature.

Differences in Outcomes in Patients with Stable Coronary Artery Disease Managed by Cardiologists versus Non-cardiologists: the International Prospective Clarify Registry Differences in Outcomes in Patients with Stable Coronary Artery Disease Managed by Cardiologists versus Non-cardiologists: the Int

J. Tardif, K. Fox, R. Ferrari, 2022 .

Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities.

T. S. Chee, D. S. Kim, S. H. Lee, 2021, European journal of preventive cardiology.

Familial transmission of a serious disease--producing group A streptococcus clone: case reports and review.

E. Kaplan, M. Martinelli, D. Stevens, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

J. Le Heuzey, J. Healey, J. Camm, 2019, Thrombosis Journal.

Dapagliflozin for heart failure according to body mass index: the DELIVER trial

Akshay S. Desai, A. Desai, J. McMurray, 2022, European heart journal.

A Case Report of Coronary Fistula with ST Segment Elevation Myocardial Infarction

M. Gamba, 2017 .

First Mexican statement in Heart Failure

G. Sánchez, Genaro Zavala, S. Leal, 2021 .

Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine

G. Mancia, R. Asmar, S. Taddei, 2015, Journal of hypertension.

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

G. Breithardt, H. Crijns, P. Mclaughlin, 2016, Journal of the American Heart Association.

Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities.

T. S. Chee, D. S. Kim, S. H. Lee, 2022, European journal of preventive cardiology.

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

Pedro F. Campos, Luciano Lopes de Sousa, Howard D. Rubenstein, 2023, European heart journal.